Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118]. Article uri icon

Overview

publication date

  • October 8, 2020

Identity

Scopus Document Identifier

  • 85092115269

Digital Object Identifier (DOI)

  • 10.1016/j.bcp.2020.114223

PubMed ID

  • 33039815

Additional Document Info

volume

  • 182